Haleon (HLN) Pension (2021 - 2026)

Haleon's (HLN) quarterly Pension came in at -$148.9 million in Q2 2026, up 2.5% on a QoQ basis from -$152.7 million in Q4 2025.

Haleon (HLN) Pension (2021 - 2026) Analysis & Trends

Haleon (HLN) has 6 years of Pension data on file, last reported at -$148.9 million in Q2 2026.

Quarterly Pension changed N/A year-over-year to -$148.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$148.9 million (changed N/A YoY) and the FY2025 annual result came in at -$151.6 million, down 190.56% from the prior year.
Pension climbed to -$148.9 million in Q2 2026, from -$152.7 million in the prior quarter.
In the past five years, Pension ranged from a high of $194.9 million in Q4 2023 to a low of -$200.2 million in Q2 2023.
A 5-year average of -$38.5 million and a median of -$150.8 million in 2025 frame the typical range for Pension.
Annual changes were most pronounced in 2024 — Pension grew 10.48% — and 2025, when it slumped 190.84%.
Tracing HLN's Pension over 5 years: stood at $188.8 million in 2022, then gained by 3.19% to $194.9 million in 2023, then fell by 13.71% to $168.1 million in 2024, then tumbled by 190.84% to -$152.7 million in 2025, then increased by 2.5% to -$148.9 million in 2026.
The last three Pension figures came in at -$148.9 million (Q2 2026), -$152.7 million (Q4 2025), and $168.1 million (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn
3	Zoetis	31.79 Bn	30.11 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.69 Bn	22.89 Bn	5.10 Bn
5	United Therapeutics	22.25 Bn	19.58 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.58 Bn	15.19 Bn	935.80 Mn
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-
10	Alkermes	8.15 Bn	7.49 Bn	397.90 Mn

Download Data